Trial intelligence / Profile preview

Intraventricular DepoCyt in Recurrent Glioblastoma

NCT01044966Phase 2Terminated

Sponsor
Medical University of South Carolina
Start
Sep 2009
Primary completion
Aug 2013
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 2 trial of liposomal cytarabine in glioblastoma (GBM), sponsored by Medical University of South Carolina. Started Sep 2009; status: terminated.

02

Drugs

liposomal cytarabine
03

Conditions

glioblastoma (GBM)

Beyond the preview

Go deeper on NCT01044966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01044966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call